Last quarter (Q3 2023), ACADIA Pharmaceuticals's total revenue was $211.70M, an increase of 61.96% from the same quarter last year. In Q3, ACADIA Pharmaceuticals's net income was $-65.18M. See ACADIA Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 631.89M	$ 517.24M	$ 484.14M	$ 441.75M	$ 339.08M	$ 223.81M
Cost of Revenue	$ 21.34M	$ 10.17M	$ 19.14M	$ 20.55M	$ 19.60M	$ 18.33M
Gross Profit	$ 605.73M	$ 507.07M	$ 465.00M	$ 421.20M	$ 319.48M	$ 205.48M
Operating Expense	$ 760.11M	$ 730.66M	$ 635.44M	$ 707.79M	$ 566.02M	$ 452.92M
Operating Income	$ -154.39M	$ -223.60M	$ -170.44M	$ -286.59M	$ -246.54M	$ -247.44M
Net Non Operating Interest Income Expense	$ 16.11M	$ 6.61M	$ 591.00K	$ 6.61M	$ 11.16M	$ 5.35M
Other Income Expense	$ -6.65M	$ -3.54M	$ -2.33M	$ -997.00K	$ 997.00K	$ -1.84M
Pretax Income	$ -131.59M	$ -213.44M	$ -167.52M	$ -280.97M	$ -234.38M	$ -243.94M
Tax Provision	$ 17.14M	$ 2.53M	$ 351.00K	$ 611.00K	$ 876.00K	$ 1.26M
Earnings From Equity Interest Net Of Tax	$ -213.44M	$ -213.44M	$ -167.52M	-	-	-
Net Income Common Stockholders	$ -148.83M	$ -215.97M	$ -167.87M	$ -281.58M	$ -235.26M	$ -245.19M
Basic EPS	$ -1.62	$ -1.34	$ -1.05	$ -1.79	$ -1.60	$ -1.94
Diluted EPS	$ -0.92	$ -1.34	$ -1.05	$ -1.79	$ -1.60	$ -1.94
Basic Average Shares	$ 162.75M	$ 161.68K	$ 160.49K	$ 157.33M	$ 147.20M	$ 126.58M
Diluted Average Shares	$ 162.75M	$ 161.68K	$ 160.49K	$ 157.33M	$ 147.20M	$ 126.58M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 781.45M	$ 740.83M	$ 654.58M	$ 728.34M	$ 585.62M	$ 471.25M
Net Income From Continuing And Discontinued Operation	$ -148.81M	$ -215.97M	$ -167.87M	$ -281.58M	$ -235.26M	$ -245.19M
Normalized Income	$ 4.98M	-	-	$ -281.58M	$ -235.26M	$ -245.19M
Interest Expense	-	-	-	-	-	-
EBIT	$ -135.22M	$ -213.44M	$ -167.52M	$ -286.59M	$ -246.54M	$ -247.44M
EBITDA	$ -138.69M	$ -214.18M	$ -161.81M	$ -283.65M	$ -243.78M	$ -244.44M

Currency in USD

ACADIA Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing